Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients

Schiesser D, Binet F, Tsinalis D, Dickenmann M, Keusch G, Schmidli M, Ambühl P, Lüthi L, Wüthrich R. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006; 21:2841-5.